These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8529300)

  • 41. [Comparative examination of intermediate molecular weight compound values in both ultrafiltrate and blood of patients with chronic renal failure].
    Popławski A; Kaliszewicz Z; Cieślak M; Popławska T
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):452-4. PubMed ID: 8170808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal Disease.
    Pai SM; Yamada H
    Clin Pharmacol Drug Dev; 2021 May; 10(5):463-470. PubMed ID: 33788422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of sertraline and desmethylsertraline in human serum using copolymeric bonded-phase extraction, liquid chromatography and gas chromatography-mass spectrometry.
    Rogowsky D; Marr M; Long G; Moore C
    J Chromatogr B Biomed Appl; 1994 Apr; 655(1):138-41. PubMed ID: 8061822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Doxycycline pharmacokinetics in chronic kidney failure patients treated by hemodialysis].
    Słuczanowski W
    Ann Acad Med Stetin; 1981; 27():313-30. PubMed ID: 7345952
    [No Abstract]   [Full Text] [Related]  

  • 45. Sertraline in diabetic neuropathy: preliminary results.
    Goodnick PJ; Jimenez I; Kumar A
    Ann Clin Psychiatry; 1997 Dec; 9(4):255-7. PubMed ID: 9511950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution and excretion of sertraline and N-desmethylsertraline in human milk.
    Kristensen JH; Ilett KF; Dusci LJ; Hackett LP; Yapp P; Wojnar-Horton RE; Roberts MJ; Paech M
    Br J Clin Pharmacol; 1998 May; 45(5):453-7. PubMed ID: 9643617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of sertraline (Zoloft) and its major metabolite in postmortem specimens by gas and liquid chromatography.
    Logan BK; Friel PN; Case GA
    J Anal Toxicol; 1994; 18(3):139-42. PubMed ID: 8065122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sertraline concentrations and postmortem redistribution.
    McIntyre IM; Mallett P
    Forensic Sci Int; 2012 Nov; 223(1-3):349-52. PubMed ID: 23131307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene.
    Matzke GR; Frye RF; Alexander AC; Reynolds R; Dixon R; Johnston J; Rault RM
    J Clin Pharmacol; 1996 Feb; 36(2):144-51. PubMed ID: 8852390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis.
    Spigset O; Hägg S; Stegmayr B; Dahlqvist R
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):699-703. PubMed ID: 11214779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal function.
    Cefali EA; Poynor WJ; Sica D; Cox S
    J Clin Pharmacol; 1991 Sep; 31(9):808-14. PubMed ID: 1804864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gas chromatographic-mass spectrometric analysis and preliminary human pharmacokinetics of sertraline, a new antidepressant drug.
    Fouda HG; Ronfeld RA; Weidler DJ
    J Chromatogr; 1987 Jun; 417(1):197-202. PubMed ID: 3624397
    [No Abstract]   [Full Text] [Related]  

  • 53. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
    Wang LH; Lee CS; Majeske BL; Marbury TC
    Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sertraline does not alter steady-state concentrations or renal clearance of lithium in healthy volunteers.
    Apseloff G; Wilner KD; von Deutsch DA; Henry EB; Tremaine LM; Gerber N; Lazar JD
    J Clin Pharmacol; 1992 Jul; 32(7):643-6. PubMed ID: 1640004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elimination of non-ionic contrast medium by hemodialysis in patients with impaired renal function.
    Horiuchi K; Yoshida K; Tsuboi N; Akimoto M; Tajima H; Kumazaki T
    Nihon Ika Daigaku Zasshi; 1999 Oct; 66(5):305-7. PubMed ID: 10547995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sertraline intoxication in a child.
    Kaminski CA; Robbins MS; Weibley RE
    Ann Emerg Med; 1994 Jun; 23(6):1371-4. PubMed ID: 8198316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of hemodialysis on tubular electrolyte transport in chronic kidney insufficiency].
    Emanuél' VI; Riabov SI; Monin IuG; Spiridonov VN; Lavrova EA
    Urol Nefrol (Mosk); 1980; (3):55-9. PubMed ID: 7385480
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients.
    Gupta SK; Kantesaria B; Glue P
    Eur J Clin Pharmacol; 2012 Apr; 68(4):415-8. PubMed ID: 22037562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of sertraline and desmethylsertraline in human plasma and red blood cells.
    Vatassery GT; Holden LA; Hazel DK; Dysken MW
    Clin Biochem; 1997 Oct; 30(7):565-8. PubMed ID: 9399026
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of Sertraline in Hemodialysis Patients.
    Kubanek A; Paul P; Przybylak M; Kanclerz K; Rojek JJ; Renke M; Bidzan L; Grabowski J
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.